The epidemiology of DSM-III-R bipolar I disorder in a general population survey RC Kessler, DR Rubinow, C Holmes, JM Abelson, S Zhao Bipolar Disorder, 11-21, 2019 | 819 | 2019 |
Towards an improved investment approach for an effective response to HIV/AIDS B Schwartländer, J Stover, T Hallett, R Atun, C Avila, E Gouws, M Bartos, ... The Lancet 377 (9782), 2031-2041, 2011 | 663 | 2011 |
A review of sex differences in the epidemiology of tuberculosis CB Holmes, H Hausler, P Nunn The International Journal of Tuberculosis and Lung Disease 2 (2), 96-104, 1998 | 618 | 1998 |
Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa CB Holmes, E Losina, RP Walensky, Y Yazdanpanah, KA Freedberg Clinical infectious diseases 36 (5), 652-662, 2003 | 418 | 2003 |
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis JR Arribas, AL Pozniak, JE Gallant, E DeJesus, B Gazzard, RE Campo, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (1), 74-78, 2008 | 336 | 2008 |
Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire SJ Goldie, Y Yazdanpanah, E Losina, MC Weinstein, X Anglaret, ... New England Journal of Medicine 355 (11), 1141-1153, 2006 | 335 | 2006 |
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment CB Holmes, R Wood, M Badri, S Zilber, B Wang, G Maartens, H Zheng, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (4), 464-469, 2006 | 266 | 2006 |
Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics MM Kavanagh, NA Erondu, O Tomori, VJ Dzau, EA Okiro, A Maleche, ... The Lancet 395 (10238), 1735-1738, 2020 | 225 | 2020 |
HIV development assistance and adult mortality in Africa E Bendavid, CB Holmes, J Bhattacharya, G Miller Jama 307 (19), 2060-2067, 2012 | 207 | 2012 |
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050 R Granich, JG Kahn, R Bennett, CB Holmes, N Garg, C Serenata, ... PloS one 7 (2), e30216, 2012 | 205 | 2012 |
Reframing HIV care: putting people at the centre of antiretroviral delivery C Duncombe, S Rosenblum, N Hellmann, C Holmes, L Wilkinson, M Biot, ... Tropical Medicine & International Health 20 (4), 430-447, 2015 | 200 | 2015 |
Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting M Shah, E Variava, CB Holmes, A Coppin, JE Golub, J McCallum, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 52 (2), 145-151, 2009 | 199 | 2009 |
Sustainable HIV treatment in Africa through viral-load-informed differentiated care A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ... Nature 528 (7580), S68-S76, 2015 | 176 | 2015 |
Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR) NS Padian, CB Holmes, SI McCoy, R Lyerla, PD Bouey, EP Goosby JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (3), 199-203, 2011 | 156 | 2011 |
Scale-up of HIV treatment through PEPFAR: a historic public health achievement WM El-Sadr, CB Holmes, P Mugyenyi, H Thirumurthy, T Ellerbrock, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 60, S96-S104, 2012 | 144 | 2012 |
Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs CB Holmes, W Coggin, D Jamieson, H Mihm, R Granich, P Savio, M Hope, ... JAMA 304 (3), 313-320, 2010 | 127 | 2010 |
The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals P Ehrenkranz, S Rosen, A Boulle, JW Eaton, N Ford, MP Fox, A Grimsrud, ... PLoS medicine 18 (5), e1003651, 2021 | 122 | 2021 |
A review of differentiated service delivery for HIV treatment: effectiveness, mechanisms, targeting, and scale M Roy, C Bolton Moore, I Sikazwe, CB Holmes Current HIV/AIDS Reports 16, 324-334, 2019 | 115 | 2019 |
Understanding preferences for HIV care and treatment in Zambia: evidence from a discrete choice experiment among patients who have been lost to follow-up A Zanolini, K Sikombe, I Sikazwe, I Eshun-Wilson, P Somwe, ... PLoS medicine 15 (8), e1002636, 2018 | 108 | 2018 |
HIV drug resistance in low-income and middle-income countries RL Hamers, TFR de Wit, CB Holmes The Lancet HIV 5 (10), e588-e596, 2018 | 102 | 2018 |